Literature DB >> 6311470

Increased sensitivity to natural killing in Raji cells is due to effector recognition of molecules appearing on target cell membranes following EBV cycle induction.

B A Blazar, J Fitzgerald, L Sutton, M Strome.   

Abstract

Previous studies demonstrated that NK resistant Epstein-Barr virus (EBV) carrying human lymphoblastoid cell lines become sensitive to NK cell-mediated destruction following induction of the viral cycle by superinfection with the P3HR-1 substrain of EBV or chemicals. In the present report we analysed the cellular membrane changes that were related to the development of sensitivity to NK activity in Raji cells with metabolic inhibitors. NK sensitivity does not develop in P3HR-1 superinfected Raji cells that are cultured in the presence of the RNA synthesis inhibitor actinomycin D and drops to half the amount usually detected in superinfected cells that are grown with the protein synthesis inhibitor cyclohexamide. In experiments with cyclohexamide blocks removed after 24 h, the target cell sensitivity to NK returns to normal levels. Control Raji cells cultured with the same inhibitors for up to 72 h do not develop any sensitivity to NK cell activity. These findings suggest that the development of sensitivity to NK destruction in Raji cells following superinfection is due to the addition to the cell membrane of a virally promoted molecule(s) that requires active RNA and protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311470      PMCID: PMC1536181     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.

Authors:  S I Schlager; M D Boyle; S H Ohanian; T Borsos
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

2.  Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.

Authors:  G Klein; L Dombos; B Gothoskar
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

3.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

Authors:  M A Epstein; B G Achong; Y M Barr; B Zajac; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1966-10       Impact factor: 13.506

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

6.  Cytotoxicity of human peripheral lymphocytes for glioma, osteosarcoma, and glia cell lines.

Authors:  H Skurzak; L Steiner; E Klein; E Lamon
Journal:  Natl Cancer Inst Monogr       Date:  1973-06

7.  Reactivity of lymphocytes from normal persons on cultured tumor cells.

Authors:  M Takasugi; M R Mickey; P I Terasaki
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

8.  Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations.

Authors:  M Jondal; H Pross
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

9.  An in vitro method for study of human lymphocyte cytotoxicity against mumps-virus-infected target cells.

Authors:  T Andersson; V Stejskal; B Harfast
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

10.  Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.